Alps Group Inc(ALPS)

Biotechnology · Kuala Lumpur, WP

$0.39-0.01 (-2.50%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

Alps Group (ALPS) Price/Sales Ratio: History & Chart | TGMCharts

PS Ratio: N/A

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T13:30:28.832Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:30:28.832Z.

Quote observation: 2026-10-06T13:30:02.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 64,896,129
TTM revenue · period ending 2025-09-30: N/A

FMP input reference: 473da95602fdb42a5f780e5c02853506da999e38a33e04168dea7648cb5c925f

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ALPS PS Ratio Metrics

PS RATIO

N/A

ALPS Competitors' PS Ratio

ALPS

Alps Group Inc

Current

Market Cap

$64.90M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDSB

PDS Biotechnology Corporation

vs ALPS

Market Cap

$64.31M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOSS

Gossamer Bio, Inc.

vs ALPS

Market Cap

$65.51M

PS Ratio

1.23

TTM Avg

6.22

3Y Avg

5.05

5Y Avg

5.05

CING

Cingulate Inc.

vs ALPS

Market Cap

$63.98M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KLRS

Kalaris Therapeutics Inc

vs ALPS

Market Cap

$63.30M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INCR

InterCure Ltd.

vs ALPS

Market Cap

$62.78M

PS Ratio

0.79

TTM Avg

0.69

3Y Avg

0.95

5Y Avg

1.63

ACET

Adicet Bio, Inc.

vs ALPS

Market Cap

$60.95M

PS Ratio

N/A

TTM Avg

16.03

3Y Avg

122.62

5Y Avg

125.37

CSBR

Champions Oncology, Inc.

vs ALPS

Market Cap

$68.91M

PS Ratio

1.14

TTM Avg

1.46

3Y Avg

1.57

5Y Avg

1.74

FBIO

Fortress Biotech, Inc.

vs ALPS

Market Cap

$69.43M

PS Ratio

1.01

TTM Avg

1.59

3Y Avg

0.87

5Y Avg

1.13

INKT

MiNK Therapeutics, Inc.

vs ALPS

Market Cap

$60.33M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Alps Group Inc (ALPS)	$64.90M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$64.31M	N/A	N/A	N/A	N/A
Gossamer Bio, Inc. (GOSS)vs ›	$65.51M	1.23	6.22	5.05	5.05
Cingulate Inc. (CING)vs ›	$63.98M	N/A	N/A	N/A	N/A
Kalaris Therapeutics Inc (KLRS)vs ›	$63.30M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$62.78M	0.79	0.69	0.95	1.63
Adicet Bio, Inc. (ACET)vs ›	$60.95M	N/A	16.03	122.62	125.37
Champions Oncology, Inc. (CSBR)vs ›	$68.91M	1.14	1.46	1.57	1.74
Fortress Biotech, Inc. (FBIO)vs ›	$69.43M	1.01	1.59	0.87	1.13
MiNK Therapeutics, Inc. (INKT)vs ›	$60.33M	N/A	N/A	N/A	N/A

How this was calculated

The four-quarter calculation detail is unavailable for this stored observation.

The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.

These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio: N/A

ALPS PS Ratio Metrics

ALPS Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

Related Metrics